CN Patent

CN105980381A — 取代的尿嘧啶及其用途

Assigned to Bayer Pharma AG · Expires 2016-09-28 · 10y expired

What this patent protects

本发明涉及新的式(I)的取代尿嘧啶衍生物，其制备方法，其单独或组合用于治疗和/或预防疾病的用途，及其用于制备用于治疗和/或预防疾病的药物的用途。

USPTO Abstract

本发明涉及新的式(I)的取代尿嘧啶衍生物，其制备方法，其单独或组合用于治疗和/或预防疾病的用途，及其用于制备用于治疗和/或预防疾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105980381A
Jurisdiction
CN
Classification
—
Expires
2016-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.